Ona Therapeutics
PrivateLast Round
Series B
Jun 4, 2026
Total Funding Raised
$122.3M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Ona Therapeutics is a biopharmaceutical company developing first-in-class antibody-drug conjugates (ADCs) to address treatment-resistant cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ona Therapeutics Comparables
Compare Ona Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adcendo | 81% | |
| Adcentrx Therapeutics | 80% | |
| Novartis | 80% | |
Ona Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 4, 2026 | ||||
| Series A | Jun 16, 2020 | ||||
| Seed | May 21, 2019 |
Key People
Founding team and executive leadership
Ona Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series B, Series A |
| Alta Life Sciences | Series A, Series B |
| Fund+ | Series A, Series B |
| Korys | Series B |
| Ysios Capital | Series A, Series B |
| Bpifrance | Series B |
| Center for Technological Development and Innovation | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2026
$87M round led by Mérieux Equity Partners and Columbus Venture Partners.
- Mar 14, 2025
Monthly visitors increased 123% MoM.
Ona Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ona Therapeutics's valuation, stock price, and market status.